Evidence map›Paper›PMID 30638679›Full record

ReviewCellular immunology2019

Modulation of autoimmune arthritis by environmental 'hygiene' and commensal microbiota.

David Langan, Eugene Y Kim, Kamal D Moudgil

Open access · greenAbstract readReview
In one paragraph

Review in Cellular immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Engineering live attenuated vaccines: Old dogs learning new tricks.Journal of translational autoimmunity · 2023
    Review
  5. Review
  6. Review
  7. Review
  8. Common innate pathways to autoimmune disease.Clinical immunology (Orlando, Fla.) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

David LanganDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, United States; Baltimore VA Medical Center, Baltimore, MD 21201, United States.
Eugene Y KimDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, United States; Department of Biomedical Sciences, Washington State University, Spokane, WA 99224, United States.
Kamal D MoudgilDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, United States; Department of Medicine, Division of Rheumatology, University of Maryland School of Medicine, Baltimore, MD 21201, United States; Baltimore VA Medical Center, Baltimore, MD 21201, United States. Electronic address: kmoudgil@som.umaryland.edu.
Baltimore VA Medical Center · USUniversity of Maryland, Baltimore · US

Funding

Immune Modulation of Autoimmunity by Herbal ProductsR01AT004321 · NCCIH · UNIVERSITY OF MARYLAND BALTIMORE · PI MOUDGIL, KAMAL D · 2009 to 2012
$1.5M
Anti-arthritic activity and therapeutic use of novel joint-homing peptidesI01BX002424 · VA · BALTIMORE VA MEDICAL CENTER · PI MOUDGIL, KAMAL D · 2015 to 2018
–
BLRD VA I01 BX002424NCCIH NIH HHS R01 AT004321
6 · The paper itself

Abstract

Observations in patients with autoimmune diseases and studies in animal models of autoimmunity have revealed that external environmental factors including exposure to microbes and the state of the host gut microbiota can influence susceptibility to autoimmunity and subsequent disease development. Mechanisms underlying these outcomes continue to be elucidated. These include deviation of the cytokine response and imbalance between pathogenic versus regulatory T cell subsets. Furthermore, specific commensal organisms are associated with enhanced severity of arthritis in susceptible individuals, while exposure to certain microbes or helminths can afford protection against this disease. In addition, the role of metabolites (e.g., short-chain fatty acids, tryptophan catabolites), produced either by the microbes themselves or from their action on dietary products, in modulation of arthritis is increasingly being realized. In this context, re-setting of the microbial dysbiosis in RA using prebiotics, probiotics, or fecal microbial transplant is emerging as a promising approach for the prevention and treatment of arthritis. It is hoped that advances in defining the interplay between gut microbiota, dietary products, and bioactive metabolites would help in the development of therapeutic regimen customized for the needs of individual patients in the near future.

Indexed as

AnimalsArthritis, RheumatoidAutoimmune DiseasesAutoimmunityDysbiosisGastrointestinal MicrobiomeHumansT-Lymphocyte SubsetsArthritisAryl hydrocarbon receptorAutoimmunityHygiene hypothesisIndolesMetabolitesMicrobiomeMicrobiotaNatural productsPrebioticsProbioticsRheumatoid arthritisShort-chain fatty acidsTh17/Treg balanceTryptophan

Identifiers

PMID30638679
PMCPMC8056395
OpenAlexW2905312201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.